Loading
1910 Genetics
1910 Genetics is a biotechnology company integrating AI, computation and biological automation to accelerate the design of small molecule and protein therapeutics. Their mission is to decrease the timeline and cost of drug development, while improving the success rate of bring innovative medicines to patients in need.
Funding
Every round, secondary, debt facility or acquisition involving 1910 Genetics that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—